PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition
Recruiting
This is a proof-of-concept phase 2 clinical trial to investigate the safety and effect of the phytoestrogenic supplement PhytoSERM on regional brain metabolism by fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in peri- and postmenopausal women. The investigators hypothesize that there will be a significant difference between the PhytoSERM group and placebo group in glucose brain metabolism.
Gender:
ALL
Ages:
Between 45 years and 60 years
Trial Updated:
01/29/2025
Locations: The Alzheimer's Prevention Program / Weill Cornell Medicine, New York, New York
Conditions: Menopause, Cognitive Change, Brain Disorder, Metabolic
A Study to Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate
Recruiting
The primary objective of the study is to estimate the prevalence of major congenital malformations (MCMs) and compare the prevalence between the diroximel fumarate (DRF) and comparator groups. The secondary objectives of the study are to estimate the incidence of spontaneous abortion (SA) and compare the incidence between the DRF and comparator groups; to estimate the incidence of preterm birth and compare the incidence between the DRF and comparator groups; to estimate the incidence of stillbir... Read More
Gender:
FEMALE
Ages:
Between 18 years and 49 years
Trial Updated:
01/29/2025
Locations: OptumInsight, Eden Prairie, Minnesota
Conditions: Multiple Sclerosis
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
Recruiting
NYC CONNECT will carry out a randomized controlled trial (RCT) which will assess the relative effectiveness of two evidence-based strategies to increase cancer screening rates for breast, cervical, and colorectal cancer. The RCT will compare the effectiveness of using a combination of 1) culturally and linguistically tailored cancer education materials and 2) community health workers (CHWs) to provide navigation services for cancer screening (the "patient navigation" \[PN\] arm) versus providing... Read More
Gender:
ALL
Ages:
Between 21 years and 75 years
Trial Updated:
01/29/2025
Locations: Albert Einstein College of Medicine, Bronx, New York +1 locations
Conditions: Cancer Screening
Study of Tucatinib and Doxil in Participants with Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Recruiting
This clinical trial is evaluating tucatinib in combination with Doxil in participants with human epidermal growth factor 2 positive (HER2+) locally advanced or metastatic breast cancer. The main goals of this study are to: * Learn how well the combination of tucatinib and Doxil works * Learn more about the side effects of the combination of tucatinib and Doxil
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/29/2025
Locations: Maryland Oncology Hematology, Columbia, Maryland +7 locations
Conditions: Breast Cancer
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Recruiting
The main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/29/2025
Locations: Denver Hip & Knee, Inc., Parker, Colorado +15 locations
Conditions: Knee Pain Chronic, Osteoarthritis, Knee, Rheumatoid Arthritis, Traumatic Arthritis, Polyarthritis, Varus Deformity, Valgus Deformity, Flexion Deformity of Knee, Avascular Necrosis
Lived Experiences of Black Girls in Richmond
Recruiting
This study is to understand the quality of life of Black Girls in Richmond, Virginia, which includes generating a report about the status of Black girls in Richmond. Research or reports about the state of the girls are growing more common across the country in cities like Los Angeles, Chicago, and Philadelphia. Most of these studies generate deficit narratives focusing on these groups' problems, needs, and deficiencies. Fewer studies focus solely on the experience of Black girls specifically. Th... Read More
Gender:
ALL
Ages:
12 years and above
Trial Updated:
01/29/2025
Locations: Virginia Commonwealth University, Richmond, Virginia
Conditions: Lived Experiences, Strengths, and Community Assets of Black Girls
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
Recruiting
Prostate cancer is the most common non-skin cancer among Veterans and the second leading cause of male cancer death. Current methods of screening men for prostate cancer are inaccurate and cannot identify which men do not have prostate cancer or have low-grade cases that will not cause harm and which men have significant prostate cancer needing treatment. False-positive screening tests can result in unnecessary prostate biopsies for men who do not need them. However, new genetic testing might he... Read More
Gender:
MALE
Ages:
Between 55 years and 69 years
Trial Updated:
01/29/2025
Locations: VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston, Massachusetts
Conditions: Prostate Cancer
National Institute of Diabetes and Digestive Kidney Diseases* Share Plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with Type 1 Diabetes* and Their Care Partners to Improve Time in Range and Reduce Diabetes Distress.
Recruiting
The purpose of this study is to test the Share plus intervention aimed at improving the use of data sharing between people with diabetes and their care partners in order to maximize the benefits of continuous glucose monitoring. Hypothesis: Compared to the control group, persons with diabetes enrolled in the Share plus intervention group will experience clinically significant improvements in time-in-range (TIR) (\>5%) at 12- and 24-weeks into the study, and improvement on diabetes distress. Car... Read More
Gender:
ALL
Ages:
60 years and above
Trial Updated:
01/29/2025
Locations: University of Utah College of Nursing, Salt Lake City, Utah
Conditions: Diabetes Mellitus, Type 1
Minimally Displaced Femoral Neck Fracture Pilot Study
Recruiting
The goal of this randomized pilot study is to assess feasibility of the trial and to collect information to inform the design of a definitive trial. Adult patients ages 60 years or older with a low-energy minimally displaced femoral neck fracture (FNF) treated with surgery will be eligible to participate in the study. Patients will be randomized to one of two treatment groups, hip arthroplasty or internal fixation. Participants will be followed for 1 year.
Gender:
ALL
Ages:
60 years and above
Trial Updated:
01/29/2025
Locations: University of Southern California, Los Angeles, California +10 locations
Conditions: Femoral Neck Fractures
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Recruiting
This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/29/2025
Locations: University of California, San Diego, San Diego, California +3 locations
Conditions: Metastatic Breast Cancer, Lobular Breast Carcinoma
Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
Recruiting
A placebo-controlled trial in which male and female outpatients with an opioid use disorder who express interest in extended-release injectable naltrexone (XR-NTX) are randomized 1:1 to lofexidine/pregabalin or lofexidine/pregabalin placebo for withdrawal management and offered XR-NTX if after completing withdrawal.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/29/2025
Locations: Mountain Manor Treatment Center, Baltimore, Maryland +1 locations
Conditions: Opiate Withdrawal Syndrome, Opioid Use
Mobile App Logging for Diabetes in Pregnancy
Recruiting
To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
Gender:
FEMALE
Ages:
Between 18 years and 100 years
Trial Updated:
01/29/2025
Locations: Augusta University, Augusta, Georgia
Conditions: Gestational Diabetes Mellitus in Pregnancy, Type 2 Diabetes